Skip to main content
TipRanks
Go Ultimate75% OFF

Iovance Biotherapeutics (IOVA) Balance Sheet

4,339 Followers

Iovance Biotherapeutics Balance Sheet

Iovance Biotherapeutics's total assets for Q3 2026 were $991.21M, an increase of 8.27% from the previous quarter. IOVA total liabilities were $178.55M for the fiscal quarter, a 0.52% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetDec 25Dec 24Dec 23Dec 22Dec 21
$ 913.17M$ 910.43M$ 780.35M$ 663.98M$ 777.33M
$ 214.59M$ 200.02M$ 195.74M$ 164.34M$ 155.67M
$ 698.58M$ 710.40M$ 584.61M$ 499.64M$ 621.66M

Currency in USD

Iovance Biotherapeutics Liabilities to Assets

0400M800M1.2B0 %10 %20 %30 %LiabilitiesLiabilities to Assets201720182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets